Cargando…
Correction to: Nuclear medicine in the assessment and prevention of cancer therapy‑related cardiotoxicity: prospects and proposal of use by the European Association of Nuclear Medicine (EANM)
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852205/ https://www.ncbi.nlm.nih.gov/pubmed/36409318 http://dx.doi.org/10.1007/s00259-022-06039-6 |
| _version_ | 1784872564027293696 |
|---|---|
| author | Totzeck, Matthias Aide, Nicolas Bauersachs, Johann Bucerius, Jan Georgoulias, Panagiotis Herrmann, Ken Hyafil, Fabien Kunikowska, Jolanta Lubberink, Mark Nappi, Carmela Rassaf, Tienush Saraste, Antti Sciagra, Roberto Slart, Riemer H.J.A. Verberne, Hein Rischpler, Christoph |
| author_facet | Totzeck, Matthias Aide, Nicolas Bauersachs, Johann Bucerius, Jan Georgoulias, Panagiotis Herrmann, Ken Hyafil, Fabien Kunikowska, Jolanta Lubberink, Mark Nappi, Carmela Rassaf, Tienush Saraste, Antti Sciagra, Roberto Slart, Riemer H.J.A. Verberne, Hein Rischpler, Christoph |
| author_sort | Totzeck, Matthias |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9852205 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98522052023-01-21 Correction to: Nuclear medicine in the assessment and prevention of cancer therapy‑related cardiotoxicity: prospects and proposal of use by the European Association of Nuclear Medicine (EANM) Totzeck, Matthias Aide, Nicolas Bauersachs, Johann Bucerius, Jan Georgoulias, Panagiotis Herrmann, Ken Hyafil, Fabien Kunikowska, Jolanta Lubberink, Mark Nappi, Carmela Rassaf, Tienush Saraste, Antti Sciagra, Roberto Slart, Riemer H.J.A. Verberne, Hein Rischpler, Christoph Eur J Nucl Med Mol Imaging Correction Springer Berlin Heidelberg 2022-11-21 2023 /pmc/articles/PMC9852205/ /pubmed/36409318 http://dx.doi.org/10.1007/s00259-022-06039-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Totzeck, Matthias Aide, Nicolas Bauersachs, Johann Bucerius, Jan Georgoulias, Panagiotis Herrmann, Ken Hyafil, Fabien Kunikowska, Jolanta Lubberink, Mark Nappi, Carmela Rassaf, Tienush Saraste, Antti Sciagra, Roberto Slart, Riemer H.J.A. Verberne, Hein Rischpler, Christoph Correction to: Nuclear medicine in the assessment and prevention of cancer therapy‑related cardiotoxicity: prospects and proposal of use by the European Association of Nuclear Medicine (EANM) |
| title | Correction to: Nuclear medicine in the assessment and prevention of cancer therapy‑related cardiotoxicity: prospects and proposal of use by the European Association of Nuclear Medicine (EANM) |
| title_full | Correction to: Nuclear medicine in the assessment and prevention of cancer therapy‑related cardiotoxicity: prospects and proposal of use by the European Association of Nuclear Medicine (EANM) |
| title_fullStr | Correction to: Nuclear medicine in the assessment and prevention of cancer therapy‑related cardiotoxicity: prospects and proposal of use by the European Association of Nuclear Medicine (EANM) |
| title_full_unstemmed | Correction to: Nuclear medicine in the assessment and prevention of cancer therapy‑related cardiotoxicity: prospects and proposal of use by the European Association of Nuclear Medicine (EANM) |
| title_short | Correction to: Nuclear medicine in the assessment and prevention of cancer therapy‑related cardiotoxicity: prospects and proposal of use by the European Association of Nuclear Medicine (EANM) |
| title_sort | correction to: nuclear medicine in the assessment and prevention of cancer therapy‑related cardiotoxicity: prospects and proposal of use by the european association of nuclear medicine (eanm) |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852205/ https://www.ncbi.nlm.nih.gov/pubmed/36409318 http://dx.doi.org/10.1007/s00259-022-06039-6 |
| work_keys_str_mv | AT totzeckmatthias correctiontonuclearmedicineintheassessmentandpreventionofcancertherapyrelatedcardiotoxicityprospectsandproposalofusebytheeuropeanassociationofnuclearmedicineeanm AT aidenicolas correctiontonuclearmedicineintheassessmentandpreventionofcancertherapyrelatedcardiotoxicityprospectsandproposalofusebytheeuropeanassociationofnuclearmedicineeanm AT bauersachsjohann correctiontonuclearmedicineintheassessmentandpreventionofcancertherapyrelatedcardiotoxicityprospectsandproposalofusebytheeuropeanassociationofnuclearmedicineeanm AT buceriusjan correctiontonuclearmedicineintheassessmentandpreventionofcancertherapyrelatedcardiotoxicityprospectsandproposalofusebytheeuropeanassociationofnuclearmedicineeanm AT georgouliaspanagiotis correctiontonuclearmedicineintheassessmentandpreventionofcancertherapyrelatedcardiotoxicityprospectsandproposalofusebytheeuropeanassociationofnuclearmedicineeanm AT herrmannken correctiontonuclearmedicineintheassessmentandpreventionofcancertherapyrelatedcardiotoxicityprospectsandproposalofusebytheeuropeanassociationofnuclearmedicineeanm AT hyafilfabien correctiontonuclearmedicineintheassessmentandpreventionofcancertherapyrelatedcardiotoxicityprospectsandproposalofusebytheeuropeanassociationofnuclearmedicineeanm AT kunikowskajolanta correctiontonuclearmedicineintheassessmentandpreventionofcancertherapyrelatedcardiotoxicityprospectsandproposalofusebytheeuropeanassociationofnuclearmedicineeanm AT lubberinkmark correctiontonuclearmedicineintheassessmentandpreventionofcancertherapyrelatedcardiotoxicityprospectsandproposalofusebytheeuropeanassociationofnuclearmedicineeanm AT nappicarmela correctiontonuclearmedicineintheassessmentandpreventionofcancertherapyrelatedcardiotoxicityprospectsandproposalofusebytheeuropeanassociationofnuclearmedicineeanm AT rassaftienush correctiontonuclearmedicineintheassessmentandpreventionofcancertherapyrelatedcardiotoxicityprospectsandproposalofusebytheeuropeanassociationofnuclearmedicineeanm AT sarasteantti correctiontonuclearmedicineintheassessmentandpreventionofcancertherapyrelatedcardiotoxicityprospectsandproposalofusebytheeuropeanassociationofnuclearmedicineeanm AT sciagraroberto correctiontonuclearmedicineintheassessmentandpreventionofcancertherapyrelatedcardiotoxicityprospectsandproposalofusebytheeuropeanassociationofnuclearmedicineeanm AT slartriemerhja correctiontonuclearmedicineintheassessmentandpreventionofcancertherapyrelatedcardiotoxicityprospectsandproposalofusebytheeuropeanassociationofnuclearmedicineeanm AT verbernehein correctiontonuclearmedicineintheassessmentandpreventionofcancertherapyrelatedcardiotoxicityprospectsandproposalofusebytheeuropeanassociationofnuclearmedicineeanm AT rischplerchristoph correctiontonuclearmedicineintheassessmentandpreventionofcancertherapyrelatedcardiotoxicityprospectsandproposalofusebytheeuropeanassociationofnuclearmedicineeanm |